Results 151 to 160 of about 82,635 (293)

Development of Styryl‐Modified 3,4‐Dihydropyrimidin‐2(1H)‐ones as Potential Antitumor Agents

open access: yesChemMedChem, Volume 21, Issue 7, 14 April 2026.
Styryl‐modified 3,4‐dihydropyrimidin‐2(1H)‐ones (DHPMs), designed from the Eg5 inhibitor monastrol, show markedly enhanced antiproliferative activity in HeLa and MCF‐7 cancer cells. Lead compounds 16 and 17 trigger apoptosis through cell‐line‐specific pathways and downregulate c‐Myc, emerging as promising anticancer candidates.
Konstantinos Panagoulias   +10 more
wiley   +1 more source

Unique Function of Kinesin Kif5A in Localization of Mitochondria in Axons [PDF]

open access: bronze, 2014
Philip D. Campbell   +5 more
openalex   +1 more source

Ca2+ Dependent Dimerization of Kinesin-CaM and Kinesin-M13 Fusion Proteins [PDF]

open access: bronze, 2011
Kiyoshi Nakazato   +4 more
openalex   +1 more source

Correction: Kinesin-3 mediated axonal delivery of presynaptic neurexin stabilizes dendritic spines and postsynaptic components

open access: gold, 2022
Devyn Oliver   +6 more
openalex   +2 more sources

Synthetic studies on mitotic kinesin Eg5 inhibitors: Synthesis and structure–activity relationships of novel 2,4,5-substituted-1,3,4-thiadiazoline derivatives

open access: green, 2014
Junichiro Yamamoto   +13 more
openalex   +1 more source

Catastrophic Kinesins [PDF]

open access: yesCell, 2004
Ems-McClung, Stephanie C   +1 more
openaire   +1 more source

Structural studies of kinesin-related proteins complexed to microtubules

open access: diamond, 2000
K. Hirose   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy